SE8303626D0 - A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced - Google Patents

A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced

Info

Publication number
SE8303626D0
SE8303626D0 SE8303626A SE8303626A SE8303626D0 SE 8303626 D0 SE8303626 D0 SE 8303626D0 SE 8303626 A SE8303626 A SE 8303626A SE 8303626 A SE8303626 A SE 8303626A SE 8303626 D0 SE8303626 D0 SE 8303626D0
Authority
SE
Sweden
Prior art keywords
protein
plasmid
igf
growth factor
human insulin
Prior art date
Application number
SE8303626A
Other languages
English (en)
Inventor
A Elmblad
G Palm
S Josephson
L-O Heden
E Holmgren
Original Assignee
Kabigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabigen Ab filed Critical Kabigen Ab
Priority to SE8303626A priority Critical patent/SE8303626D0/sv
Publication of SE8303626D0 publication Critical patent/SE8303626D0/sv
Priority to IT21436/84A priority patent/IT1175508B/it
Priority to EP84850197A priority patent/EP0130166A1/en
Priority to JP59129038A priority patent/JPS6019493A/ja
Priority to GB08416007A priority patent/GB2142033A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
SE8303626A 1983-06-23 1983-06-23 A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced SE8303626D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8303626A SE8303626D0 (sv) 1983-06-23 1983-06-23 A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
IT21436/84A IT1175508B (it) 1983-06-23 1984-06-15 Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodotta
EP84850197A EP0130166A1 (en) 1983-06-23 1984-06-20 A recombinant plasmid, a transformant microorganism, a polydeoxy-ribonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
JP59129038A JPS6019493A (ja) 1983-06-23 1984-06-22 組換え体プラスミド,形質転換体微生物,ポリデオキシリボヌクレオチド断片,生物学的に活性な蛋白質およびその製法
GB08416007A GB2142033A (en) 1983-06-23 1984-06-22 Human insulin-like growth factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8303626A SE8303626D0 (sv) 1983-06-23 1983-06-23 A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced

Publications (1)

Publication Number Publication Date
SE8303626D0 true SE8303626D0 (sv) 1983-06-23

Family

ID=20351747

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303626A SE8303626D0 (sv) 1983-06-23 1983-06-23 A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced

Country Status (5)

Country Link
EP (1) EP0130166A1 (sv)
JP (1) JPS6019493A (sv)
GB (1) GB2142033A (sv)
IT (1) IT1175508B (sv)
SE (1) SE8303626D0 (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
GB8522977D0 (en) * 1985-09-17 1985-10-23 Fujisawa Pharmaceutical Co Production of insulin-like growth factor 1
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
GB8507833D0 (en) * 1985-03-26 1985-05-01 Biogen Nv Production of human somatomedin c
JPH07114702B2 (ja) * 1985-10-21 1995-12-13 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲i▼の製造法
JPH0817708B2 (ja) * 1986-10-09 1996-02-28 藤沢薬品工業株式会社 Met−インスリン様成長因子Iの発現ベクター
JPH03505966A (ja) * 1988-07-14 1991-12-26 ベイラー カレッジ オブ メディシン 生物高分子の固相組立及び再構築方法
ATE143696T1 (de) * 1989-02-28 1996-10-15 Canon Kk Partiell doppelsträngiges oligonukleotid und verfahren zu seiner bildung
JP2682738B2 (ja) * 1989-06-09 1997-11-26 グロペップ プロプライエタリー リミテッド 成長ホルモン融合蛋白質
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
EP0586667A1 (en) * 1992-03-24 1994-03-16 Synergen, Inc. Refolding and purification of insulin-like growth factor i
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US7097974B1 (en) 1998-08-28 2006-08-29 Febit Biotech Gmbh Support for a method for determining an analyte and a method for producing the support
EP1728860B1 (de) 1999-02-19 2010-01-27 febit holding GmbH Verfahren zur Herstellung von Polymeren
PT3520823T (pt) 2005-05-02 2021-09-16 Genzyme Corp Terapia genética para distúrbios neurometabólicos
AU2006242129A1 (en) 2005-05-02 2006-11-09 Genzyme Corporation Gene therapy for spinal cord disorders
AR059088A1 (es) * 2006-01-20 2008-03-12 Genzyme Corp Administracion intraventricular de una proteina para esclerosis lateral amiotrofica
AR059089A1 (es) 2006-01-20 2008-03-12 Genzyme Corp Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
PT1988823T (pt) 2006-02-09 2018-11-22 Genzyme Corp Administração intraventricular lenta
PT2029742T (pt) 2006-06-07 2016-09-09 Genzyme Corp Terapia genética para esclerose lateral amiotrófica e outros transtornos da medula espinal
EP3146982B1 (en) 2006-10-03 2019-08-21 Genzyme Corporation Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201918A (en) * 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone

Also Published As

Publication number Publication date
GB8416007D0 (en) 1984-07-25
JPS6019493A (ja) 1985-01-31
GB2142033A (en) 1985-01-09
IT8421436A1 (it) 1985-12-15
EP0130166A1 (en) 1985-01-02
IT8421436A0 (it) 1984-06-15
IT1175508B (it) 1987-07-01

Similar Documents

Publication Publication Date Title
SE8303626D0 (sv) A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
ATE240394T1 (de) Methoden zur herstellung löslicher, oligomerer proteine
DE69534822D1 (de) Verfahren zur bakteriellen herstellung von heterologen polypeptiden mit disulfidbrücke
EP0136907A3 (en) A xenogeneic expression control system, a method of using it, expression vectors containing it, cells transformed thereby and heterologous proteins produced therefrom
ATE125865T1 (de) Rekombinante humicola-lipase und verfahren zur herstellung von rekombinanten humicola-lipasen.
ATE123520T1 (de) Kex2-endoprotease und verfahren zu ihrer herstellung.
FI102539B1 (sv) DNA-fragment, som kodar en polypeptid med nitrilhydratasaktivitet, transformant innehållande genen och förfarande för framställning av amider med hjälp av transformanten
AU1509188A (en) Secretion of insulin-like growth factor-I in E. Coli
HUT42523A (en) Process for preparing thrombine inhibitors
DE3683267D1 (de) Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung.
KR930013115A (ko) Dna 분자 및 숙주
DE3879823T2 (de) Verfahren zur herstellung von menschlichem wachstumshormon.
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
BR8406680A (pt) Processo para preparacao de um plasmidio,processo para expressao eficiente de proteinas heterologas,para preparacao de um transformante e processo para producao de prorrenina
GR3021040T3 (en) Process for production of stranger protein in streptomycetes
SE8505921D0 (sv) A method to export gene products to the growth medium of gram negative bacteria
GR3022653T3 (en) A process for refolding of (pro-)chymosin, comprising recycling of urea.
DK0387646T3 (da) Achromobacter-protease I-gen og genprodukt deraf
ATE184915T1 (de) Verfahren zur herstellung von vakzinen und ihre verwendung
DE3681398D1 (de) Verfahren zur herstellung von insulinaehnlichem wachstumsfaktor i (igf-i) und plasmid zu dessen herstellung.
ATE60802T1 (de) Mikrobiologisches verfahren zur herstellung von menschlichem lysozym.
IT1202612B (it) Plasmidi ricombinanti utili per l'espressione in bacillus di proteine eterologhe
ATE122097T1 (de) Expressionsvektor und verfahren zur regulierbaren herstellung von proteinen in eukaryonten.
ES8704513A1 (es) Un metodo para producir una proteina heterologa